Therapeutic blood levels of sirolimus (rapamycin) in the allografted rat.
A study was conducted to determine the relationship among oral dose, trough whole blood levels, graft survival, and side effects in sirolimus-treated allografted rats. The heterotopic heart allograft model using Brown Norway donors and Lewis rat recipients was used. Rats were dosed daily with sirolimus or vehicle until graft failure or up to a maximum of 28 days. Upon graft failure, rats were bled for measurement of trough blood levels of drug and tissues sent for histopathologic analysis. Sirolimus blood concentration correlated positively with dose and graft survival. Significant graft survival occurred at whole blood trough levels of 0.5 ng/ml achieved at the 0.3 mg/kg/day dose. Analysis of the concentration-effect data using a sigmoidal Emax model calculated a whole blood EC50 of 2.0 ng/ml for graft survival. With mean trough concentrations of 7 ng/ml and higher, grafts survived after cessation of drug treatment. At the 0.8 mg/kg/day dose, there was a significant decrease in body weight gain in the rats. Histopathologic examination of sirolimus-treated animals detected thymic and lymphoid atrophy, both considered pharmacologic extensions of sirolimus's immunosuppressive activity and focal myocardial degeneration, an exacerbation of a spontaneous occurring lesion. These results demonstrate that sirolimus prolongs graft survival in rat in a concentration dependent manner with therapeutic whole blood levels of about 10 ng/ml.
Wyeth-Ayerst Research, Princeton, New Jersey 08543-8000, USA.
J F
JF
DiJoseph
E
E
Fluhler
J
J
Armstrong
M
M
Sharr
S N
SN
Sehgal
D000818:Animals; D001835:Body Weight; D006085:Graft Survival / Q000187:drug effects; D016027:Heart Transplantation / Q000276:immunology / Q000473:pathology; D007166:Immunosuppressive Agents / Q000097:blood* / Q000627:therapeutic use; D011090:Polyenes / Q000097:blood* / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D020123:Sirolimus; D014184:Transplantation, Homologous / Q000276:immunology* / Q000473:pathology
D007166:Immunosuppressive Agents; D011090:Polyenes; D020123:Sirolimus